CJC no-DAC / Ipamorelin
Combination GHRH analog and ghrelin-receptor agonist studied for growth-hormone pulse research.


Vial concentration
CJC no-DAC / Ipamorelin
10 mgThis is a clinician-reviewed research peptide. Pricing is provided as part of an approved, personalized plan after your assessment is reviewed.
Not sure where to start?
Discover what may fit your goals — a short, personalized Regenexa Assessment.
Take Your Assessment →- 🔒 Secure & encrypted checkout
- 📦 Fast, discreet worldwide shipping
- 🧪 Pharmaceutical-grade quality
- 🔬 Research use only
Pairs a GHRH-receptor agonist (CJC-1295 No DAC) with a ghrelin-receptor agonist (Ipamorelin) — two distinct receptor pathways studied together for an additive GH-pulse effect, a common combination rationale in this research area.
Receptors
Half-life: Short — dominated by the CJC-1295 No DAC component's ~30-minute half-life.
Ask Regenexa AI about CJC no-DAC / Ipamorelin
Get plain-language answers on mechanism, evidence and how it compares to other peptides — grounded in Regenexa's verified data.
Ask Regenexa AI →
Tesamorelin
IGF-1 LR3
Ipamorelin
CJC-1295 With DAC